Coronavirus Update: After Trump Pressure, US FDA Issues Emergency Use Authorization For Blood Plasma Therapy

Agency Reverses Decision

24 Aug 2020

• By Scrip Team

US FDA Commissioner Stephen Hahn cites 35% improvement in study, but critics are dismayed by fudging of science and political pressure.

Plasma — The Emergency Use Authorization will expand access to convalescent blood plasma - but a lack of a placebo-controlled study remains a cause for concern.

More from COVID-19

More from Scrip